424B3: Prospectus
EFFECT: Others
S-3: Registration statement for specified transactions by certain issuers
8-K: Current report
424B5: Prospectus
8-K: Current report
8-K: Current report
8-K: Current report
10-Q: Quarterly report
8-K: Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
8-K: Current report
8-K: Current report
8-K: Current report
Dermata Therapeutics | ARS: Annual Report to Security Holders
Dermata Therapeutics | DEFA14A: Others
Dermata Therapeutics | DEF 14A: Definitive information statements
Dermata Therapeutics | 10-K: Annual report
Dermata Therapeutics | 8-K: Current report
Dermata Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Dermata Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
No Data